Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2026-06-08 21:19:23 ET · period of report 2026-06-05 · accession 0001193125-26-262671 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-08 21:19 | 2026-06-05 | XENE | Cannon Gillian | Dir | S - Sale | $53.14 | -1,190 | 1,455 | -45% | -$63.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-06-05 | S | D | 1,190 | $53.14 | 1,455 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 15, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025. |